0001567619-20-020818.txt : 20201209
0001567619-20-020818.hdr.sgml : 20201209
20201209175325
ACCESSION NUMBER: 0001567619-20-020818
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201207
FILED AS OF DATE: 20201209
DATE AS OF CHANGE: 20201209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anicetti Vincent R
CENTRAL INDEX KEY: 0001733375
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36721
FILM NUMBER: 201378815
MAIL ADDRESS:
STREET 1: COHERUS BIOSCIENCES, INC.
STREET 2: 333 TWIN DOLPHIN DRIVE, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Coherus BioSciences, Inc.
CENTRAL INDEX KEY: 0001512762
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 273615821
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 333 TWIN DOLPHIN DR, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: (650) 649-3530
MAIL ADDRESS:
STREET 1: C/O DENNIS M. LANFEAR
STREET 2: 333 TWIN DOLPHIN DR, SUITE 600
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: BioGenerics, Inc.
DATE OF NAME CHANGE: 20110210
4
1
doc1.xml
FORM 4
X0306
4
2020-12-07
0
0001512762
Coherus BioSciences, Inc.
CHRS
0001733375
Anicetti Vincent R
COHERUS BIOSCIENCES, INC.
333 TWIN DOLPHIN DRIVE, SUITE 600
REDWOOD CITY
CA
94065
0
1
0
0
Chief Operating Officer
Common Stock
2020-12-07
4
M
0
3000
12.37
A
35569
D
Common Stock
2020-12-07
4
M
0
5791
12.70
A
41360
D
Common Stock
2020-12-07
4
S
0
8791
18.4161
D
32569
D
Stock Option (Right to Buy)
12.37
2020-12-07
4
M
0
3000
0.00
D
2029-01-11
Common Stock
3000
123000
D
Stock Option (Right to Buy)
12.7
2020-12-07
4
M
0
5791
0.00
D
2027-08-06
Common Stock
5791
0
D
Includes 31,250 restricted stock units.
The transaction was executed in multiple trades in prices ranging from $18.30 to $18.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
All of the shares underlying this option are vested and exercisable as of the date hereof.
/s/ Jean-Frederic Viret, as Attorney-in-Fact for Vincent R. Anicetti
2020-12-09